Biocon Establishes Strategic Licensing and Supply Agreement with Tabuk Pharmaceutical
Sep 27, 2024
Pharmaceutical Invest Information
Lupin Signs Patent License Agreement with Takeda
Sep 19, 2024
Dr Reddy's Labs Andhra Pradesh Facility Receives EIR from USFDA
Sep 7, 2024
Biocon Subsidiary Signs Deal for Biosimilar Distribution in Global Markets
Aug 30, 2024
Piramal Pharma Reports Diminished Net Loss in Q1FY25
Jul 27, 2024
Zydus Secures USFDA Approval for Valsartan Tablets, a Boost for the Pharmaceutical Industry
Jul 23, 2024
SciSparc Ltd. to Spin Off Advanced Clinical Stage Pharmaceutical Portfolio
Jul 8, 2024
U.S. President Joe Biden Urges Novo Nordisk and Eli Lilly to Cut Obesity Drug Prices
Jul 3, 2024
Dr Reddy's Stocks Surge Following Nicotinell Brand Acquisition Despite Brokerage Skepticism
Jun 28, 2024
Diverse Public Company Updates in the Latest Market News
Jun 22, 2024
Eisai Submits LEQEMBI® (lecanemab-irmb) Biologics License Update to FDA for Early Alzheimer's Treatment – Biogen Stocks in Focus
Jun 10, 2024
Piramal Pharma Limited Publishes Q4 and Annual Financial Results for 2024
May 13, 2024
Immix Biopharma Receives EU Orphan Drug Designation for NXC-201 in Multiple Myeloma
Apr 29, 2024
Projected Expansion of Global Contraceptive Drugs Market to USD 28.96 Billion by 2030
Mar 13, 2024
Analysis of Notable Stocks: LLY, NVDA, CMG, CAVA, DELL
Mar 9, 2024
Charles River (CRL) Anticipated to Reveal Growth in Q4 Earnings
Feb 2, 2024
Dow Climbs While Archer-Daniels-Midland Suffers a Setback
Jan 23, 2024
Projected Growth in Global Clinical Trials Outsourcing Market to Hit USD 74.38 Billion by 2031
Jan 16, 2024
Pharmaceutical Chemicals Market Projected to Reach USD 339.3 Billion by 2031
Jan 15, 2024
Bristol Myers Squibb's Repotrectinib Under EMA Review for NSCLC Treatment
Jan 4, 2024
Dividend Duel: Telecommunication Giant AT&T vs. Biopharma Leader AbbVie
Dec 18, 2023
SciSparc Announces Intention to Acquire Leading Vehicle Importer in Israel
Dec 7, 2023
ROSEN, Trial Attorneys Urge SCYNEXIS Investors to Act Before Critical Securities Class Action Deadline - SCYX
Nov 12, 2023
StockNews.com Initiates Coverage on Lipocine (LPCN), Impacts of Institutional Trading Highlighted
Nov 12, 2023
Investment Strategies and Stock Insights with Jim Cramer on CNBC's 'Mad Money'
Nov 11, 2023
Valneva SE's VALN Chikungunya Vaccine Receives FDA Approval, Company's Stock Rises
Nov 10, 2023
GENFIT Announces Third Quarter 2023 Financial Outcomes and Update on R&D Progress
Nov 10, 2023